Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome

Safa Najidh, Cornelis P. Tensen, Alita J. van der Sluijs-Gelling, Cristina Teodosio, Davy Cats, Hailiang Mei, Thomas B. Kuipers, Jacoba J. Out-Luijting, Willem H. Zoutman, Thorbald van Hall, Alberto Orfao, Julia Almeida, Jacques J. M. van Dongen, Maarten H. Vermeer

Blood (2021) 138 (24): 2539–2554.

https://doi.org/10.1182/blood.2021012286

Published: 2021

Includes: Supplemental data

Journal Articles

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

Blood (2019) 134 (24): 2218–2222.

https://doi.org/10.1182/blood.2019002610

Published: 2019

Includes: Supplemental data

Journal Articles

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab

Anton W. Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo, Kirsten Fischer, Michael Steurer, Marek Trněný, Stephen P. Mulligan, Ulrich J. M. Mey, Kerstin Trunzer, Günter Fingerle-Rowson, Kathryn Humphrey, Stephan Stilgenbauer, Sebastian Böttcher, Monika Brüggemann, Michael Hallek, Michael Kneba, Jacques J. M. van Dongen

Blood (2019) 133 (5): 494–497.

https://doi.org/10.1182/blood-2018-03-839688

Published: 2019

Includes: Supplemental data

Journal Articles

A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL

Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle-Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek

Blood (2018) 131 (9): 955–962.

https://doi.org/10.1182/blood-2017-06-792333

Published: 2018

Includes: Supplemental data

Journal Articles

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

Blood (2017) 129 (3): 347–357.

https://doi.org/10.1182/blood-2016-07-726307

Published: 2017

Includes: Supplemental data

Journal Articles

XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination

Hanna IJspeert, Jacob Rozmus, Klaus Schwarz, René L. Warren, David van Zessen, Robert A. Holt, Ingrid Pico-Knijnenburg, Erik Simons, Isabel Jerchel, Angela Wawer, Myriam Lorenz, Turkan Patıroğlu, Himmet Haluk Akar, Ricardo Leite, Nicole S. Verkaik, Andrew P. Stubbs, Dik C. van Gent, Jacques J. M. van Dongen, Mirjam van der Burg

Blood (2016) 128 (5): 650–659.

https://doi.org/10.1182/blood-2016-02-701029

Published: 2016

Includes: Supplemental data

Journal Articles

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

Blood (2016) 127 (25): 3165–3174.

https://doi.org/10.1182/blood-2016-03-705319

Published: 2016

Includes: Supplemental data

Journal Articles

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Jacques J. M. van Dongen, Vincent H. J. van der Velden, Monika Brüggemann, Alberto Orfao

Blood (2015) 125 (26): 3996–4009.

https://doi.org/10.1182/blood-2015-03-580027

Published: 2015

Journal Articles

New criteria for response assessment: role of minimal residual disease in multiple myeloma

Bruno Paiva, Jacques J. M. van Dongen, Alberto Orfao

Blood (2015) 125 (20): 3059–3068.

https://doi.org/10.1182/blood-2014-11-568907

Published: 2015

Journal Articles

B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma

Vincent H. J. van der Velden, Patricia G. Hoogeveen, Dick de Ridder, Magdalena Schindler-van der Struijk, Menno C. van Zelm, Mathijs Sanders, Dennis Karsch, H. Berna Beverloo, King Lam, Alberto Orfao, Pieternella J. Lugtenburg, Sebastian Böttcher, Jacques J. M. van Dongen, Anton W. Langerak, Mies Kappers-Klunne, Kirsten van Lom

Blood (2014) 124 (3): 412–419.

https://doi.org/10.1182/blood-2013-10-533869

Published: 2014

Includes: Supplemental data

Journal Articles

B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency

Gertjan J. Driessen, Menno C. van Zelm, P. Martin van Hagen, Nico G. Hartwig, Margreet Trip, Adilia Warris, Esther de Vries, Barbara H. Barendregt, Ingrid Pico, Wim Hop, Jacques J. M. van Dongen, Mirjam van der Burg

Blood (2011) 118 (26): 6814–6823.

https://doi.org/10.1182/blood-2011-06-361881

Published: 2011

Includes: Supplemental data

Journal Articles

Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways

Magdalena A. Berkowska, Gertjan J. A. Driessen, Vasilis Bikos, Christina Grosserichter-Wagener, Kostas Stamatopoulos, Andrea Cerutti, Bing He, Katharina Biermann, Johan F. Lange, Mirjam van der Burg, Jacques J. M. van Dongen, Menno C. van Zelm

Blood (2011) 118 (8): 2150–2158.

https://doi.org/10.1182/blood-2011-04-345579

Published: 2011

Includes: Supplemental data

Journal Articles

IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells

Sonja E. Nodland, Magdalena A. Berkowska, Anna A. Bajer, Nisha Shah, Dick de Ridder, Jacques J. M. van Dongen, Tucker W. LeBien, Menno C. van Zelm

Blood (2011) 118 (8): 2116–2127.

https://doi.org/10.1182/blood-2010-08-302513

Published: 2011

Includes: Supplemental data

Journal Articles

Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling

Tiago C. Luis, Brigitta A. E. Naber, Willem E. Fibbe, Jacques J. M. van Dongen, Frank J. T. Staal

Blood (2010) 116 (3): 496–497.

https://doi.org/10.1182/blood-2010-04-282624

Published: 2010

Journal Articles

Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients

Mirjam van der Burg, Malgorzata Pac, Magdalena A. Berkowska, Bozenna Goryluk-Kozakiewicz, Anna Wakulinska, Bozenna Dembowska-Baginska, Hanna Gregorek, Barbara H. Barendregt, Malgorzata Krajewska-Walasek, Ewa Bernatowska, Jacques J. M. van Dongen, Krystyna H. Chrzanowska, Anton W. Langerak

Blood (2010) 115 (23): 4770–4777.

https://doi.org/10.1182/blood-2009-10-250514

Published: 2010

Journal Articles

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Blood (2010) 115 (16): 3206–3214.

https://doi.org/10.1182/blood-2009-10-248146

Published: 2010

Includes: Supplemental data

Journal Articles

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Blood (2010) 115 (16): 3215–3223.

https://doi.org/10.1182/blood-2009-06-230250

Published: 2010

Includes: Supplemental data

Journal Articles

Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation

Tiago C. Luis, Floor Weerkamp, Brigitta A. E. Naber, Miranda R. M. Baert, Edwin F. E. de Haas, Tatjana Nikolic, Sjanneke Heuvelmans, Ronald R. De Krijger, Jacques J. M. van Dongen, Frank J. T. Staal

Blood (2009) 113 (3): 546–554.

https://doi.org/10.1182/blood-2008-06-163774

Published: 2009

Journal Articles

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma

David González, Mirjam van der Burg, Ramón García-Sanz, James A. Fenton, Anton W. Langerak, Marcos González, Jacques J. M. van Dongen, Jesus F. San Miguel, Gareth J. Morgan

Blood (2007) 110 (9): 3112–3121.

https://doi.org/10.1182/blood-2007-02-069625

Published: 2007

Journal Articles

Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL

Willem A. Dik, Bertrand Nadel, Grzegorz K. Przybylski, Vahid Asnafi, Piotr Grabarczyk, Jean Marc Navarro, Brenda Verhaaf, Christian A. Schmidt, Elizabeth A. Macintyre, Jacques J. M. van Dongen, Anton W. Langerak

Blood (2007) 110 (1): 388–392.

https://doi.org/10.1182/blood-2006-12-064816

Published: 2007

Includes: Supplemental data

NARROW

Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab

A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

New criteria for response assessment: role of minimal residual disease in multiple myeloma

B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma

B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency

Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways

IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells

Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling

Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation

Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma

Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only